Case Study: a leading global biopharma client achieves an optimal oncology sales force strategy with Axtria

a leading global biopharma client optimizes oncology go-to-market with Axtria for a 2nd-leading cause of death market

The customer, a leading global biopharma client, faced the challenge of structuring an effective go-to-market strategy for a new oncology indication launch in the US. They needed to assess their overall strategy to ensure a successful product launch. Vendor Axtria applied its expertise in Promotion Response Model (PRM) and Sales Force Structure and Strategy (SFSS) projects to address this.

Axtria recommended the optimal sales force size and structure for different future market scenarios, providing multiple options with revenue impact analysis for the new indication. This transformation resulted in an efficient sales force size for the brands, made the client more capable of promoting its drug portfolio effectively, and led to the implementation of the recommended structure in the field.